Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-02-01 @ 6:52 AM
Study NCT ID:
NCT03119467
Status:
TERMINATED
Last Update Posted:
2019-12-27
First Post:
2017-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords: